XYL Earnings & Financial Statements
Xylem Inc.
$102.74
+$0.20(+0.20%)
53
Overall
85
Value
18
Tech
57
Quality
Market Cap
$23.94B
Volume
2.43M
52W Range
$98.58 - $154.27
Target Price
$147.50
XYL earnings and financial statements: Xylem Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
XYL Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $9.04B | $8.56B | $7.36B | $5.52B | $5.20B |
| Cost of revenue | $5.56B | $5.35B | $4.65B | $3.44B | $3.22B |
| Operating income | $1.22B | $1.01B | $652.00M | $622.00M | $585.00M |
| EBITDA | $1.78B | $1.69B | $1.12B | $726.00M | $832.00M |
| Net income | $957.00M | $890.00M | $609.00M | $355.00M | $427.00M |
| EPS (diluted) | $3.92 | $3.65 | $2.79 | $1.96 | $2.35 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $17.63B | $16.49B | $16.11B | $7.95B | $8.28B |
| Total liabilities | $5.88B | $5.61B | $5.94B | $4.45B | $5.05B |
| Shareholders’ equity | $11.48B | $10.64B | $10.17B | $3.49B | $3.22B |
| Cash and equivalents | $1.48B | $1.12B | $1.02B | $944.00M | $1.35B |
| Long-term debt | $1.41B | $1.98B | $2.28B | $1.88B | $2.44B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $1.24B | $1.26B | $837.00M | $596.00M | $538.00M |
| Capital expenditure | -$314.00M | -$317.00M | -$271.00M | -$204.00M | -$208.00M |
| Free cash flow | $910.00M | $942.00M | $566.00M | $388.00M | $330.00M |
| Dividends paid | $391.00M | $350.00M | $299.00M | $217.00M | $203.00M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XYL | $102.74 | +0.2% | 2.43M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |